Xiubao Ren Selected Research

Xiubao Ren Research Topics

Disease

156	Neoplasms (Cancer) 05/2024 - 10/2006
42	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 11/2012
23	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2008
22	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2009
20	Lung Neoplasms (Lung Cancer) 12/2022 - 11/2011
10	Adenocarcinoma of Lung 02/2024 - 02/2015
9	Stomach Neoplasms (Stomach Cancer) 08/2022 - 01/2011
9	Inflammation (Inflammations) 01/2022 - 03/2010
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 01/2013
7	Hepatocellular Carcinoma (Hepatoma) 09/2023 - 01/2013
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 03/2012
6	Carcinoma (Carcinomatosis) 03/2023 - 01/2008
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2019
6	Carcinogenesis 06/2020 - 03/2013
5	Melanoma (Melanoma, Malignant) 03/2024 - 07/2013
5	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 08/2010
5	Disease Progression 12/2023 - 02/2015
5	Adenocarcinoma 01/2023 - 08/2010
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2024 - 04/2019
4	Esophageal Squamous Cell Carcinoma 02/2022 - 01/2019
4	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2015
4	Diarrhea 12/2020 - 01/2012
3	Bites and Stings (Sting) 02/2024 - 01/2023
3	Necrosis 01/2023 - 03/2010
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2022 - 01/2013
3	Lymphatic Metastasis 01/2022 - 10/2012
3	Infections 08/2021 - 01/2021
2	Triple Negative Breast Neoplasms 03/2024 - 06/2018
2	Tertiary Lymphoid Structures 01/2024 - 12/2022
2	Ovarian Neoplasms (Ovarian Cancer) 03/2023 - 02/2014
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 03/2020 - 01/2015
2	Glioma (Gliomas) 01/2020 - 10/2012
2	Multiple Myeloma 08/2019 - 11/2012

Drug/Important Bio-Agent (IBA)

29	CytokinesIBA 05/2024 - 11/2008
25	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2010
20	Proteins (Proteins, Gene)FDA Link 02/2024 - 08/2010
19	LigandsIBA 01/2024 - 12/2010
12	Immune Checkpoint InhibitorsIBA 01/2023 - 02/2017
12	MicroRNAs (MicroRNA)IBA 01/2019 - 12/2010
9	pembrolizumabIBA 02/2024 - 01/2015
7	EnzymesIBA 05/2024 - 09/2011
6	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2010
6	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2011
6	Tyrosine Kinase InhibitorsIBA 12/2023 - 02/2015
6	Pemetrexed (MTA)FDA Link 01/2023 - 02/2015
6	AntigensIBA 01/2020 - 02/2012
5	InterferonsIBA 02/2024 - 01/2019
5	PlatinumIBA 12/2023 - 02/2015
5	apatinibIBA 08/2022 - 11/2017
5	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2014
5	AntibodiesIBA 01/2022 - 01/2017
5	VaccinesIBA 01/2021 - 09/2002
4	Interleukin-10 (Interleukin 10)IBA 05/2024 - 02/2014
4	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 05/2024 - 11/2014
4	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2015
4	Monoclonal AntibodiesIBA 01/2024 - 01/2017
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2017
4	Programmed Cell Death 1 ReceptorIBA 01/2022 - 01/2021
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2021 - 01/2008
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 11/2014
4	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2018 - 01/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 11/2014
3	Interferon-gamma (Interferon, gamma)IBA 09/2023 - 11/2008
3	Interleukin-2 (IL2)IBA 03/2023 - 09/2016
3	Therapeutic UsesIBA 03/2023 - 09/2008
3	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 02/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 02/2014
3	camrelizumabIBA 12/2022 - 01/2021
3	Carrier Proteins (Binding Protein)IBA 01/2022 - 12/2015
3	Axitinib (AG 013736)IBA 01/2021 - 01/2015
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020 - 04/2016
3	B7-H1 AntigenIBA 01/2020 - 12/2017
3	Long Noncoding RNAIBA 01/2019 - 10/2014
2	anlotinibIBA 02/2024 - 01/2020
2	Granzymes (Granzyme)IBA 02/2024 - 01/2022
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 02/2024 - 01/2024
2	Interferon Type IIBA 02/2024 - 01/2024
2	Drug CombinationsIBA 01/2024 - 01/2023
2	Gemcitabine FDA Link 01/2024 - 01/2023
2	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 09/2023 - 01/2022
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2020
2	interleukin-21 (interleukin 21)IBA 01/2022 - 04/2012
2	Adenosine (Adenocard)FDA LinkGeneric 01/2022 - 01/2019
2	ChemokinesIBA 01/2021 - 08/2016
2	Glutamine (L-Glutamine)FDA Link 01/2021 - 01/2018
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2018
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 04/2010
2	ParaffinIBA 01/2020 - 01/2013
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2019 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2019 - 01/2015

Therapy/Procedure

51	Therapeutics 05/2024 - 10/2006
46	Immunotherapy 04/2024 - 11/2010
37	Drug Therapy (Chemotherapy) 04/2024 - 01/2009
7	Neoadjuvant Therapy 05/2023 - 03/2012
4	Gastrectomy 04/2015 - 05/2013
3	Radiotherapy 10/2021 - 01/2021
2	Immunomodulation 01/2023 - 07/2014
2	Chemoradiotherapy 02/2022 - 01/2019